Registry and CERVIVA investigators present their research findings at HPV 2015 in Portugal
The 30th International Papillomavirus Conference (HPV 2015) takes place in Lisbon, Portugal from September 17-21. The conference focuses on HPV (human papillomavirus) which is a known cause of cervical cancer and is also implemented in other diseases (e.g. oropharyngeal, anal and vulval cancers). HPV is a common viral infection that affects most men and women at some point in their lives.
Two CERVIVA researchers, Dr Christine White and Dr Mairead O’Connor, will be attending the conference and presenting important findings from some of the CERVIVA research studies. CERVIVA is a multi-disciplinary research consortium that aims to advance high-quality research in HPV-associated diseases. The Registry continues to be one of the main collaborators of CERVIVA since the research programme’s launch in 2006.
Dr White, who is based at the Coombe Women and Infants University Hospital, will be giving a poster presentation entitled: “Triage options for HPV positive women in a primary screening population”. This research is from the HPV Primary Screening Pilot Study which aims to explore the use of HPV testing as a first-line cervical screening method (i.e. instead of regular smear tests) in the national cervical cancer screening programme (CervicalCheck).
Dr O’Connor, who is based at the Registry, will have two poster presentations at the conference. The posters are based on the findings from studies conducted in the first phase of CERVIVA which explored the potential psychological impact of HPV testing on women.
The results from these studies will be used to help inform policy makers on the best options for implementing primary HPV testing into CervicalCheck. HPV 2015 will also run a number of clinical and public health workshops with world-renowned experts in HPV giving a series of talks. More information on the conference can be found here.